找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Drug Delivery Systems Based on the Tumor Microenvironment; Yasuhiro Matsumura,David Tarin Book 2019 Springer Japan KK, part of Spri

[复制链接]
楼主: monster
发表于 2025-3-25 06:10:34 | 显示全部楼层
Neutrino Physics and Astrophysics Val-Cit sequence is currently the most common choice for an enzymatic cleavable linker, novel approaches for releasing payloads, such as light stimulation and chemical reaction, have been reported. In this chapter, advances in development of linker technology will be reviewed.
发表于 2025-3-25 10:13:49 | 显示全部楼层
Lothar Oberauer,Judith Oberauergree of cancer stroma formation. This section focuses primarily on antibody-based nuclear medicine imaging targeting cancer stroma because it has the highest sensitivity and quantitative ability among the noninvasive imaging techniques applicable to clinical practice, and CAST therapy has been based on antibody-drug conjugates.
发表于 2025-3-25 12:52:33 | 显示全部楼层
发表于 2025-3-25 18:23:39 | 显示全部楼层
CAST Diagnostic Imaginggree of cancer stroma formation. This section focuses primarily on antibody-based nuclear medicine imaging targeting cancer stroma because it has the highest sensitivity and quantitative ability among the noninvasive imaging techniques applicable to clinical practice, and CAST therapy has been based on antibody-drug conjugates.
发表于 2025-3-25 21:04:48 | 显示全部楼层
发表于 2025-3-26 01:29:07 | 显示全部楼层
发表于 2025-3-26 05:36:15 | 显示全部楼层
发表于 2025-3-26 12:32:07 | 显示全部楼层
发表于 2025-3-26 14:49:22 | 显示全部楼层
ADCs on the Market and in Clinical Development of payload DNA topoisomerase I inhibitor is emerging. This review will focus on introduction of the four approved ADC drugs and promising novel ADCs with DNA topoisomerase I inhibitors, Sacituzumab Govitecan and [fam-] Trastuzumab Deruxtecan, in late stages of clinical development.
发表于 2025-3-26 18:01:02 | 显示全部楼层
Polymeric Micelles the efficacy and reducing the side effects of anticancer agents. Indeed, several micellar formulations of anticancer agents have progressed to clinical trials. This article outlines polymer micelle from the viewpoint of formulation and particle design.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-24 18:46
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表